PathoVax

RGVax is the first vaccine to prevent infection of all HPV types linked to cervical and skin cancers. This is achieved by presenting a shared HPV protein on a non-infectious, single-particle vaccine, reducing production costs while leveraging an FDA-approved platform.

Website : https://www.pathovax.com/

Call 2018

The 2018 call for applications for the Young Enterprise Initiative – Start in France is now closed for Finnish, Italian, South Korean, Taiwanese, and U.S. companies. The call will open soon for South African companies.

Country Programs

@YeiAccelerator

Newsletter

Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links